{
    "Trade/Device Name(s)": [
        "SPOTCHECK Neonatal Total Galactose Microplate Reagent Kit",
        "SPOTCHECK Pro"
    ],
    "Submitter Information": "Astoria-Pacific, Inc.",
    "510(k) Number": "K121101",
    "Predicate Device Reference 510(k) Number(s)": [
        "K991498"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JIA"
    ],
    "Summary Letter Date": "June 7, 2013",
    "Summary Letter Received Date": "June 11, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1310"
    ],
    "Regulation Name(s)": [
        "Galactose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total Galactose",
        "Galactose",
        "Galactose-1-phosphate"
    ],
    "Specimen Type(s)": [
        "Whole Blood (dried blood spot)"
    ],
    "Specimen Container(s)": [
        "Standardized filter paper (blood spot collection card)"
    ],
    "Instrument(s)/Platform(s)": [
        "Microplate absorbance reader",
        "SPOTCHECK Pro"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric enzymatic assay",
        "Microplate absorbance spectroscopy"
    ],
    "Methodologies": [
        "Enzyme reaction",
        "Spectrophotometric detection"
    ],
    "Submission Type(s)": [
        "Reagent Kit"
    ],
    "Document Summary": "FDA 510(k) summary for SPOTCHECK Neonatal Total Galactose Microplate Reagent Kit for quantitation of total galactose in neonatal whole blood dried blood spots by enzymatic colorimetric assay.",
    "Indications for Use Summary": "For quantitative determination of total galactose (galactose plus galactose-1-phosphate) in whole blood dried blood spot samples to aid in neonatal screening for galactosemia, not for monitoring purposes.",
    "fda_folder": "Clinical Chemistry"
}